Consolidated figures · ₹ crore
| ₹ Cr | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| 462 | 487 | 431 | 699 | 805 | 934 | 1,087 | 1,141 | |
| COGS | 283 | 125 | — | 174 | 196 | 64 | 115 | 151 |
| Gross profit | 179 | 362 | — | 525 | 609 | 870 | 972 | 990 |
| 97 | 280 | — | 405 | 472 | 693 | 840 | 847 | |
| 82 | 82 | — | 120 | 137 | 177 | 133 | 143 | |
| OPM % | 17.8% | 16.8% | — | 17.2% | 17% | 19% | 12.2% | 12.5% |
| Depreciation | 33 | 36 | — | 43 | 48 | 52 | 66 | 70 |
| Interest | 8 | 6 | — | 6 | 9 | 16 | 39 | 39 |
| 9 | 17 | 14 | 8 | 23 | 19 | 28 | 27 | |
| Profit before tax | 50 | 57 | 55 | 79 | 102 | 128 | 56 | 61 |
| Tax | 19 | 29 | — | 25 | 34 | 45 | 54 | 26 |
| Tax % | 37.2% | 51.4% | — | 31.8% | 33.7% | 34.9% | 96.6% | 42.7% |
| 32 | 28 | 42 | 54 | 68 | 84 | 2 | 35 | |
| PAT margin % | 6.9% | 5.7% | 9.8% | 7.7% | 8.4% | 8.9% | 0.2% | 3% |
| EPS (₹) | 2.9 | 2.6 | — | 5 | 6.3 | 7.8 | 0.2 | 3.2 |
| EPS adjusted (₹) | 2.9 | 2.6 | 3.9 | 5 | 6.3 | 7.8 | 0.6 | 3.5 |
| 17.1% | 19.6% | — | 20% | 19% | 15.4% | 0% | — | |
| Annual report | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 108 | 108 | 108 | 108 | 108 | 107 | 107 | 107 | 108 |
| Reserves | 657 | 672 | 691 | 727 | 768 | 820 | 893 | 885 | 898 |
| Minority interest | — | 0 | 0 | — | — | — | 7 | 3 | 0 |
| 91 | 57 | 49 | 44 | 155 | 181 | 314 | 427 | 540 | |
| 118 | 102 | 119 | 118 | 162 | 173 | 286 | 282 | 294 | |
| Total equity & liabilities | 975 | 939 | 967 | 997 | 1,194 | 1,281 | 1,608 | 1,704 | 1,839 |
| 647 | 692 | 672 | 650 | 657 | 685 | 966 | 955 | 1,046 | |
| CWIP | 46 | 2 | 3 | 4 | 5 | 6 | 15 | 8 | 0 |
| Investments | 10 | 11 | 28 | 16 | 25 | 146 | 81 | 95 | 62 |
| 271 | 235 | 263 | 327 | 507 | 444 | 545 | 646 | 731 | |
| Total assets | 975 | 939 | 967 | 997 | 1,194 | 1,281 | 1,608 | 1,704 | 1,839 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Healthcare Services | 1,010.14 | 95.28 | 1,264.97 | 574.16 | 690.81 | 13.79 |
| Manufacturing of Implants | 131.29 | -34.72 |
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 60 | 14 | 43 | 55 | 79 | 19 | 68 | 20 | -4 | -0 | |
| 53 | -237 | 1 | -31 | -51 | -60 | -61 | 38 | -36 | -97 | |
| -111 | 222 | -51 | -22 | -30 | 90 | -50 | -151 | 48 | 84 | |
| Net cash flow | 3 | -0 | -6 | 3 | — | 49 | -43 | -93 | 8 | -13 |
| Free cash flow | 119 | -124 | 12 | 36 | 58 | -56 | 49 | -28 | -76 | -149 |
| CFO / Operating profit % | — | — | 52.7% | 67.8% | — | 15.8% | 49.6% | 11.1% | -3.3% | -0% |
| -412.79 |
| -420.64 |
| — |
| — |
₹ crore by fiscal year